Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type

INTRODUCTION: Factors affecting trastuzumab efficacy in advanced gastric cancer (GC) are largely unknown. Heterogeneity is a notable feature of HER2 in GC. Whether the heterogeneity influences trastuzumab efficacy is still unknown. RESULTS: The HER2(homogeneous) group and HER2(heterogeneous) group s...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Xu, Chen, Liu, Yalan, Jiang, Dongxian, Li, Qian, Ge, Xiaowen, Zhang, Ying, Huang, Jie, Su, Jieakesu, Ji, Yuan, Hou, Jun, Lu, Shaohua, Hou, Yingyong, Liu, Tianshu
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2017
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464860/
https://ncbi.nlm.nih.gov/pubmed/28388541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16567
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items